Siemens to List Siemens Healthineers on Frankfurt Stock Exchange
By HospiMedica International staff writers
06 Dec 2017
Siemens AG (Munich, Germany; Munich), a provider of medical imaging and laboratory diagnostics equipment, is preparing to list its separately managed healthcare unit, Siemens Healthineers (Erlangen, Germany), on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market. The move was approved at a meeting by the company's Supervisory Board and has been planned for the first half of 2018. Siemens Healthineers AG will be established for the public listing.
"For Siemens Healthineers, the public listing is the next logical step and the foundation for expanding our strong position as a leading global supplier of healthcare technology," said Michael Sen, Chairman of the Siemens Healthineers Supervisory Board and the member of Siemens' Managing Board responsible, among other things, for healthcare technology. "Frankfurt is one of the world's largest trading centers for securities, and its importance will continue to increase due to Brexit. As a highly liquid trading venue, Frankfurt is attractive for investors from around the world. The public listing will give Siemens Healthineers entrepreneurial flexibility and access to the capital market. The goal is to grow sustainably and profitably while actively shaping the paradigm shift in the healthcare industry."
"Our preparations for the public listing are completely on schedule. The Strategy 2025 concept and the management team are in place. The legal prerequisites have largely been fulfilled," said Siemens Chief Financial Officer Ralf P. Thomas. "Deutsche Bank, Goldman Sachs International and J.P. Morgan have been engaged as global coordinators, and BNP PARIBAS, BofA Merrill Lynch, Citigroup and UBS Investment Bank as further syndicate banks."